Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 52 min ago
Peer-reviewedCC BYAlzheimer's & dementia : the journal of the Alzheimer's Association

Tau positron emission tomography harmonization using the CenTauR approach: General conversion equations, relevant cut-points, and external validation.

53 more authors

60 listed; 65 in total.

40 affiliations
  1. 1ZRO Imaging, Santiago de Compostela, Spain.
  2. 2Nuclear Medicine Department and Molecular Imaging Group, Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain.
  3. 3Eli Lilly and Company, Indianapolis, Indiana, USA.
  4. 4Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  5. 5Department of Molecular Imaging & Therapy, Austin Health, Melbourne, Victoria, Australia.
  6. 6F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  7. 7Clinical Imaging Group, Genentech, Inc., South San Francisco, California, USA.
  8. 8Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.
  9. 9Memory Clinic, Skåne University Hospital, Malmö, Sweden.
  10. 10Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  11. 11Lawrence Berkeley National Laboratory, University of California Berkeley, Berkeley, California, USA.
  12. 12Johnson & Johnson, La Jolla, California, USA.
  13. 13Life Molecular Imaging GmbH, Berlin, Germany.
  14. 14Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  15. 15Lantheus Switzerland GmbH, Basel, Switzerland.
  16. 16Ace Alzheimer Center Barcelona, Barcelona, Spain.
  17. 17Networking Research Center on Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
  18. 18Wisconsin Alzheimer's Disease Research Center, University of Wisconsin- Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
  19. 19Department of Medicine Division of Geriatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
  20. 20Department of Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  21. 21Eisai, Inc., Nutley, New Jersey, USA.
  22. 22Biogen, Inc., Cambridge, Massachusetts, USA.
  23. 23Xing Imaging - AMitro Company, London, UK.
  24. 24Advanced Neuroimaging Center, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba, Japan.
  25. 25Merck & Co., West Point, Pennsylvania, USA.
  26. 26Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, California, USA.
  27. 27Harvard Medical School, Department of Radiology, Boston, Massachusetts, USA.
  28. 28Gordon Center for Medical Imaging, Massachusetts General Hospital, Boston, Massachusetts, USA.
  29. 29Barcelonaβeta Brain Research Center, Barcelona, Spain.
  30. 30Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain.
  31. 31Critical Path for Alzheimer's Disease (CPAD) Consortium, Critical Path Institute, Tucson, Arizona, USA.
  32. 32Enigma Biomedical Group, Knoxville, Tennessee, USA.
  33. 33Neuroscience Campus Amsterdam, Alzheimer center, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  34. 34Department of Nuclear Medicine & PET Center, Huashan University Hospital, Shanghai, China.
  35. 35Department of Nuclear Medicine, LMU Hospital, Ludwig Maximilian University of Munich, Munich, Germany.
  36. 36German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
  37. 37Laboratory of Neuro Imaging, USC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Los Angeles, California, USA.
  38. 38Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  39. 39Center of Alzheimer Research, Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
  40. 40Department of Neurology, Edward and Pearl Fein Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, California, USA.

Abstract

Introduction

Tau positron emission tomography (PET) tracers differ in kinetics, binding properties, and quantification pipelines, complicating cross-study comparisons. The CenTauR approach provides a unified framework for harmonizing tau PET quantification across tracers.Methods

We defined a tracer-agnostic "Standard Method" using Statistical Parametric Mapping 12, standardized regions of interest, and harmonized acquisition parameters. Using data from five tau tracers-[¹⁸F]flortaucipir, [¹⁸F]MK-6240, [¹⁸F]PI-2620, [¹⁸F]RO948, and [¹⁸F]GTP1-we applied the Joint Propagation Model to derive linear equations converting regional standardized uptake value ratios into the tracer-independent CenTauR scale. Validation included independent cross-sectional, longitudinal, and test-retest datasets across multiple cohorts.Results

The CenTauR scale yielded highly consistent regional values across tracers, with strong cross-tracer agreement and robust performance in external validation cohorts. We also expressed clinically relevant cut-points and staging boundaries on the CenTauR scale.Discussion

The CenTauR approach enables harmonized, tracer-independent quantification of tau PET, supporting reproducibility across studies and improving interpretation in clinical research and multicenter trials.

Related

  1. Left ventricular function and volumes from cardiac magnetic resonance and gated [13N]-ammonia positron emission tomography myocardial perfusion imaging in patients with ischemia with no obstructive coronary arteries: a prospective head-to-head comparison using hybrid positron emission tomography/magnetic resonance
    Runze Wen, Qiang Xie, Ming Ni +5
    Quantitative imaging in medicine and surgeryPeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMC
  2. Gallium-68 (68Ga)-Labelled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Initial Staging of High-Risk Prostatic Adenocarcinoma: Reclassification to Oligometastatic Disease and Change in Treatment Intent
    Carlos Paul Villalba-Meneses, Adriana P Noboa, Veronica Marcela Villegas-Paredes
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Fibroblast Activation Protein Inhibitor Positron Emission Tomography Imaging in Atrial Fibrillation: Current Evidence and Future Perspectives
    Yi Xu, Huiyi Qiu, Chuxian Guo +5
    Reviews in cardiovascular medicinePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  4. Tissue‐specific insulin sensitivity in anorexia nervosa: A cross‐sectional positron emission tomography (PET) study in female adults
    Aino Latva‐Rasku, Kyoungjune Pak, Eleni Rebelos +14
    Physiological reportsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Inflammation, Scar, or Both? Interpreting Positron Emission Tomography Patterns in Cardiac Sarcoidosis
    Toshifumi Tamura, Toshiyuki Nagai, Toshihisa Anzai
    Circulation JournalPeer-reviewedCC BY-NC-NDFull textPhysiologyJ-STAGE
BibTeX
@article{rial2026positron,
  title = {{Tau positron emission tomography harmonization using the CenTauR approach: General conversion equations, relevant cut-points, and external validation.}},
  author = {Alexis Moscoso Rial and Antoine Leuzy and Lars Lau Raket and Victor L Villemagne and Gregory Klein and Matteo Tonietto and Emily Olafson and Ruben Smith and Christopher G Schwarz and Suzanne Baker and Ziad S Saad and Santiago Bullich and Brian Lopresti and Sandra Sanabria Bohorquez and Guilherme Domingues Kolinger and Olivia Lutz and Mercè Boada and Tobey J Betthauser and Arnaud Charil and Emily C Collins and Jessica A Collins and Roger N Gunn and Makoto Higuchi and Eric Hostetler and R Matthew Hutchison and Leonardo Iaccarino and Philip S Insel and Michael C Irizarry and Clifford R Jack and William J Jagust and Keith A Johnson and Sterling C Johnson and Cécile Tissot and David Vállez García and Gemma Salvadó and Diane Stephenson and Marta Marquié and Sulantha Mathotaarachchi and Mark A Mintun and Rik Ossenkoppele and Qi Huang and Xiaoxie Mao and Johannes Gnörich and Ioannis Pappas and Ronald C Petersen and Konstantinos Chiotis and Gil D Rabinovici and Pedro Rosa-Neto and Andrew W Stephens and Alex Whittington and Maria C Carrillo and Michael J Pontecorvo and Samantha Budd Haeberlein and Billy Dunn and Hartmuth C Kolb and Nadine Tatton and Yashmin Karten and Matthias Brendel and Sid O'Bryant and Fang Xie},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year = {2026},
  month = oct,
  doi = {10.1002/alz.71886},
  url = {https://europepmc.org/article/MED/42963335},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Tau positron emission tomography harmonization using the CenTauR approach: General conversion equations, relevant cut-points, and external validation.
AU  - Alexis Moscoso Rial
AU  - Antoine Leuzy
AU  - Lars Lau Raket
AU  - Victor L Villemagne
AU  - Gregory Klein
AU  - Matteo Tonietto
AU  - Emily Olafson
AU  - Ruben Smith
AU  - Christopher G Schwarz
AU  - Suzanne Baker
AU  - Ziad S Saad
AU  - Santiago Bullich
AU  - Brian Lopresti
AU  - Sandra Sanabria Bohorquez
AU  - Guilherme Domingues Kolinger
AU  - Olivia Lutz
AU  - Mercè Boada
AU  - Tobey J Betthauser
AU  - Arnaud Charil
AU  - Emily C Collins
AU  - Jessica A Collins
AU  - Roger N Gunn
AU  - Makoto Higuchi
AU  - Eric Hostetler
AU  - R Matthew Hutchison
AU  - Leonardo Iaccarino
AU  - Philip S Insel
AU  - Michael C Irizarry
AU  - Clifford R Jack
AU  - William J Jagust
AU  - Keith A Johnson
AU  - Sterling C Johnson
AU  - Cécile Tissot
AU  - David Vállez García
AU  - Gemma Salvadó
AU  - Diane Stephenson
AU  - Marta Marquié
AU  - Sulantha Mathotaarachchi
AU  - Mark A Mintun
AU  - Rik Ossenkoppele
AU  - Qi Huang
AU  - Xiaoxie Mao
AU  - Johannes Gnörich
AU  - Ioannis Pappas
AU  - Ronald C Petersen
AU  - Konstantinos Chiotis
AU  - Gil D Rabinovici
AU  - Pedro Rosa-Neto
AU  - Andrew W Stephens
AU  - Alex Whittington
AU  - Maria C Carrillo
AU  - Michael J Pontecorvo
AU  - Samantha Budd Haeberlein
AU  - Billy Dunn
AU  - Hartmuth C Kolb
AU  - Nadine Tatton
AU  - Yashmin Karten
AU  - Matthias Brendel
AU  - Sid O'Bryant
AU  - Fang Xie
PY  - 2026
DA  - 2026/10/01
JO  - Alzheimer's & dementia : the journal of the Alzheimer's Association
DO  - 10.1002/alz.71886
UR  - https://europepmc.org/article/MED/42963335
AB  - Introduction  Tau positron emission tomography (PET) tracers differ in kinetics, binding properties, and quantification pipelines, complicating cross-study comparisons. The CenTauR approach provides a unified framework for harmonizing tau PET quantification across tracers.Methods  We defined a tracer-agnostic "Standard Method" using Statistical Parametric Mapping 12, standardized regions of interest, and harmonized acquisition parameters. Using data from five tau tracers-[¹⁸F]flortaucipir, [¹⁸F]MK-6240, [¹⁸F]PI-2620, [¹⁸F]RO948, and [¹⁸F]GTP1-we applied the Joint Propagation Model to derive linear equations converting regional standardized uptake value ratios into the tracer-independent CenTauR scale. Validation included independent cross-sectional, longitudinal, and test-retest datasets across multiple cohorts.Results  The CenTauR scale yielded highly consistent regional values across tracers, with strong cross-tracer agreement and robust performance in external validation cohorts. We also expressed clinically relevant cut-points and staging boundaries on the CenTauR scale.Discussion  The CenTauR approach enables harmonized, tracer-independent quantification of tau PET, supporting reproducibility across studies and improving interpretation in clinical research and multicenter trials.
SN  - 1552-5260
SN  - 1552-5279
ER  -